These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 10544088)

  • 41. Jembrana disease virus Tat can regulate human immunodeficiency virus (HIV) long terminal repeat-directed gene expression and can substitute for HIV Tat in viral replication.
    Chen H; He J; Fong S; Wilcox G; Wood C
    J Virol; 2000 Mar; 74(6):2703-13. PubMed ID: 10684286
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The hepatitis B virus X protein induces HIV-1 replication and transcription in synergy with T-cell activation signals: functional roles of NF-kappaB/NF-AT and SP1-binding sites in the HIV-1 long terminal repeat promoter.
    Gómez-Gonzalo M; Carretero M; Rullas J; Lara-Pezzi E; Aramburu J; Berkhout B; Alcamí J; López-Cabrera M
    J Biol Chem; 2001 Sep; 276(38):35435-43. PubMed ID: 11457829
    [TBL] [Abstract][Full Text] [Related]  

  • 43. HIV-1 Tat potentiates TNF-induced NF-kappa B activation and cytotoxicity by altering the cellular redox state.
    Westendorp MO; Shatrov VA; Schulze-Osthoff K; Frank R; Kraft M; Los M; Krammer PH; Dröge W; Lehmann V
    EMBO J; 1995 Feb; 14(3):546-54. PubMed ID: 7859743
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evolution of the human immunodeficiency virus type 1 long terminal repeat promoter by conversion of an NF-kappaB enhancer element into a GABP binding site.
    Verhoef K; Sanders RW; Fontaine V; Kitajima S; Berkhout B
    J Virol; 1999 Feb; 73(2):1331-40. PubMed ID: 9882338
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reciprocal modulatory interaction between human immunodeficiency virus type 1 Tat and transcription factor NFAT1.
    Macián F; Rao A
    Mol Cell Biol; 1999 May; 19(5):3645-53. PubMed ID: 10207088
    [TBL] [Abstract][Full Text] [Related]  

  • 46. TAR-independent transactivation by Tat in cells derived from the CNS: a novel mechanism of HIV-1 gene regulation.
    Taylor JP; Pomerantz R; Bagasra O; Chowdhury M; Rappaport J; Khalili K; Amini S
    EMBO J; 1992 Sep; 11(9):3395-403. PubMed ID: 1505523
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Functional similarities between HIV-1 Tat and DNA sequence-specific transcriptional activators.
    Madore SJ; Cullen BR
    Virology; 1995 Feb; 206(2):1150-4. PubMed ID: 7856090
    [TBL] [Abstract][Full Text] [Related]  

  • 48. RNA transcripts of the human immunodeficiency virus transactivation response element can inhibit action of the viral transactivator.
    Graham GJ; Maio JJ
    Proc Natl Acad Sci U S A; 1990 Aug; 87(15):5817-21. PubMed ID: 1696012
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Examination of TAR-independent Trans activation by human immunodeficiency virus type 1 Tat in human glial cells.
    Kim YS; Panganiban AT
    J Neurosci Res; 1996 Mar; 43(6):652-66. PubMed ID: 8984195
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Methamphetamine activates nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) and induces human immunodeficiency virus (HIV) transcription in human microglial cells.
    Wires ES; Alvarez D; Dobrowolski C; Wang Y; Morales M; Karn J; Harvey BK
    J Neurovirol; 2012 Oct; 18(5):400-10. PubMed ID: 22618514
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differential regulation of HIV-1 clade-specific B, C, and E long terminal repeats by NF-kappaB and the Tat transactivator.
    Roof P; Ricci M; Genin P; Montano MA; Essex M; Wainberg MA; Gatignol A; Hiscott J
    Virology; 2002 Apr; 296(1):77-83. PubMed ID: 12036319
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cytokine augmentation of HIV-1 LTR-driven gene expression in neural cells.
    Swingler S; Easton A; Morris A
    AIDS Res Hum Retroviruses; 1992 Apr; 8(4):487-93. PubMed ID: 1599755
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human immunodeficiency viruses containing heterologous enhancer/promoters are replication competent and exhibit different lymphocyte tropisms.
    Chang LJ; McNulty E; Martin M
    J Virol; 1993 Feb; 67(2):743-52. PubMed ID: 8419644
    [TBL] [Abstract][Full Text] [Related]  

  • 54. EGCG inhibits Tat-induced LTR transactivation: role of Nrf2, AKT, AMPK signaling pathway.
    Zhang HS; Wu TC; Sang WW; Ruan Z
    Life Sci; 2012 May; 90(19-20):747-54. PubMed ID: 22480519
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An emerging and variant viral promoter of HIV-1 subtype C exhibits low-level gene expression noise.
    Ali H; Bhange D; Mehta K; Gohil Y; Prajapati HK; Byrareddy SN; Buch S; Ranga U
    Retrovirology; 2021 Sep; 18(1):27. PubMed ID: 34538278
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transcriptional activity of the human immunodeficiency virus-1 LTR promoter in fission yeast Schizosaccharomyces pombe.
    Toyama R; Bende SM; Dhar R
    Nucleic Acids Res; 1992 May; 20(10):2591-6. PubMed ID: 1598218
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cell-specific differences in activation of NF-kappa B regulatory elements of human immunodeficiency virus and beta interferon promoters by tumor necrosis factor.
    Lacoste J; D'Addario M; Roulston A; Wainberg MA; Hiscott J
    J Virol; 1990 Oct; 64(10):4726-34. PubMed ID: 2204723
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Doxorubicin inhibits Tat-dependent transactivation of HIV type 1 LTR.
    Jeyaseelan R; Kurabayashi M; Kedes L
    AIDS Res Hum Retroviruses; 1996 May; 12(7):569-76. PubMed ID: 8743082
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synergistic activation of human immunodeficiency virus type 1 promoter activity by NF-kappaB and inhibitors of deacetylases: potential perspectives for the development of therapeutic strategies.
    Quivy V; Adam E; Collette Y; Demonte D; Chariot A; Vanhulle C; Berkhout B; Castellano R; de Launoit Y; Burny A; Piette J; Bours V; Van Lint C
    J Virol; 2002 Nov; 76(21):11091-103. PubMed ID: 12368351
    [TBL] [Abstract][Full Text] [Related]  

  • 60. tat regulates binding of the human immunodeficiency virus trans-activating region RNA loop-binding protein TRP-185.
    Wu F; Garcia J; Sigman D; Gaynor R
    Genes Dev; 1991 Nov; 5(11):2128-40. PubMed ID: 1936997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.